Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction.
Hlatky
M A
MA
Owens
D K
DK
D000638:Amiodarone / Q000191:economics / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000191:economics* / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D003645:Death, Sudden; D003661:Decision Support Techniques; D006334:Heart Function Tests / Q000191:economics*; D006801:Humans; D015233:Models, Statistical; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality*; D018570:Risk Assessment; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone